David Hung is President and Chief Executive Officer of Nuvation Bio Inc. (NUVB). The company reported total compensation of $3,876,736 for fiscal year 2025.
| Salary | $650,016 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $2,674,636 |
| Non-equity incentive plan | $536,250 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $15,834 |
| Total | $3,876,736 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Nuvation Bio Inc. filed April 10, 2026, accession 0001140361-26-014157.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $650,016 | $0 | $0 | $2,674,636 | $536,250 | $0 | $15,834 | $3,876,736 |
| FY2024 | President and Chief Executive Officer | $609,835 | $0 | $0 | $2,519,960 | $571,875 | $0 | $15,684 | $3,717,354 |
Totals as disclosed in each year's own compensation disclosure for Nuvation Bio Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Hung this page | President and Chief Executive Officer | $3,876,736 |
| Philippe Sauvage | Chief Financial Officer | $1,478,677 |
| Gary Hattersley | Chief Scientific Officer | $1,472,462 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Nuvation Bio Inc. compensation brief.
David Hung's compensation sits inside Nuvation Bio Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.